Skip to main content

Table 2 Summary of PK parameters (AUC(0-t) and Cmax) in plasma by treatment

From: The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

Variable Salbutamol Treatment N Geo. Mean CV% Geo Mean CI 95% Lower GEO Mean CI 95% Upper GEO Mean
AUC(0-t) pg.h/mL 1.5 μm (50 μg) 8 773.36 38.62 566.23 1056.26
6 μm (50 μg) 8 1043.94 35.65 781.77 1394.03
Neb (2.5 mg) 8 4657.29 53.95 3052.22 7106.41
pMDI (400 μg) 9 1974.04 49.6 1376.59 2830.78
Cmax pg/mL 1.5 μm (50 μg) 8 335.94 41.54 240.65 468.96
6 μm (50 μg) 8 326.47 39.88 236.79 450.1
Neb (2.5 mg) 8 1605.95 74.91 919.19 2805.81
pMDI (400 μg) 9 794.53 34.42 614.34 1027.57